论文部分内容阅读
目的探究抗病毒治疗与介入治疗联合对乙肝相关肝癌的治疗效果。方法根据四川省绵阳市中心医院2013-01-2015-01收治的76例乙肝相关肝癌患者为研究对象,按照入院的先后顺序随机分为实验组和对照组,分别采取抗病毒联合介入治疗和单纯抗病毒治疗,分析两组治疗效果。结果实验组生存率为63.16%,对照组生存率为42.11%,两组生存率比较差异有统计学意义,实验组患者在ALT、Tbil在治疗1个月或优于对照组,差异有统计学意义;治疗3个月后ALT、Tbil、AST实验组优于对照组;ALB、AFP在治疗3、6、12个月后效果明显优于看对照组,差异有统计学意义。结论应用介入治疗联合抗病毒治疗可提高患者生存率和治疗效果,改善生活质量,值得在临床中推广应用。
Objective To investigate the therapeutic effect of combined antiviral therapy and interventional therapy on hepatocellular carcinoma associated with hepatitis B virus. Methods According to the sequence of 76 cases of hepatitis B-related liver cancer patients treated in Central Hospital of Mianyang City, Sichuan Province from January 2013 to January 2015, the patients were randomly divided into experimental group and control group according to the sequence of hospital admission. Anti-virus combined with interventional therapy Antiviral therapy, analysis of two groups of treatment. Results The survival rate of the experimental group was 63.16%, the survival rate of the control group was 42.11%, the difference between the two groups was statistically significant, the experimental group in ALT, Tbil treatment for 1 month or better than the control group, the difference was statistically significant Significance; ALT, Tbil, AST experimental group was better than control group after 3 months of treatment; ALB, AFP in 3,6,12 months after treatment was significantly better than the control group, the difference was statistically significant. Conclusion Interventional therapy combined with antiviral therapy can improve the survival rate and treatment effect of patients and improve the quality of life, which is worth popularizing and applying in clinic.